Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06106451 · ClinicalTrials.gov registry record · NA
Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)
A NA study of Aortic Valve Disease and Aortic Valve Replacement, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06106451 is a NA study of Aortic Valve Disease and Aortic Valve Replacement that has completed, run by Johns Hopkins University. The registered enrollment target is 40 participants, below the 18,614-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06106451, a NA study of Aortic Valve Disease and Aortic Valve Replacement, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators will evaluate the feasibility and potential efficacy of programs to improve functional outcomes after minimally-invasive transcatheter aortic valve replacement (TAVR). The investigators will examine the potential efficacy of (a) a motivation interviewing program, and (b) a home-based physical activity + motivational interviewing program, compared to (c) usual care + enhanced education in patients post-TAVR procedure.
Conditions Studied
Interventions
- BEHAVIORAL Standard of Care plus Enhanced Patient Education
- BEHAVIORAL Motivational Interviewing Intervention
- BEHAVIORAL Home-Based Activity Program plus Motivational Interviewing Intervention
Study Locations (1)
Maryland
- The Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2025-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06106451
The ClinicalTrials.gov registry entry for NCT06106451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,614-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aortic Valve Disease appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care plus Enhanced Patient Education is the first listed.
NCT06106451 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06106451 about?
NCT06106451 is a clinical study titled "Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)". In this study, the investigators will evaluate the feasibility and potential efficacy of programs to improve functional outcomes after minimally-invasive transcatheter aortic valve replacement (TAVR). The investigators will examine the potential efficacy of (a) a motivation interviewing program, and...
What is the current status of trial NCT06106451?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-01-29. Estimated completion is 2025-11-03.
What conditions does trial NCT06106451 study?
This clinical trial studies the following conditions: Aortic Valve Disease, Aortic Valve Replacement.
What interventions are being tested in trial NCT06106451?
The interventions under investigation include: Standard of Care plus Enhanced Patient Education (BEHAVIORAL), Motivational Interviewing Intervention (BEHAVIORAL), Home-Based Activity Program plus Motivational Interviewing Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06106451?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06106451 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The JenaValve ALIGN-AR LVAD Registry
RECRUITING · NA
-
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
RECRUITING · NA
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
-
Avalus Ultra Post-Approval Study (PAS)
ACTIVE NOT RECRUITING · NA
-
J-Valve TF Early Feasibility Study
ACTIVE NOT RECRUITING · NA
-
Early Feasibility Study for the Foldax Tria Aortic Heart Valve
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.